phase readout
saveNCT06787612: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
RECRUITINGupdated 19d ago
community read0 votes
Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
view source ↗
comments(0)
5-min edit window · permanent after that